| Entry |
|
| Name |
Fexuprazan (INN); Abeprazan |
| Formula |
C19H17F3N2O3S
|
| Exact mass |
410.0912
|
| Mol weight |
410.41
|
| Structure |

|
| Class |
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01646 Proton pump inhibitor (PPI)
|
| Remark |
|
| Efficacy |
Anti-ulcerative, Proton pump inhibitor |
| Comment |
Potassium competitive acid blocker
|
| Target |
|
| Pathway |
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BC Proton pump inhibitors
A02BC10 Fexuprazan
D13012 Fexuprazan (INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01646 Proton pump inhibitor (PPI)
D13012 Fexuprazan
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
ATPase
ATP4
D13012 Fexuprazan (INN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 28
1 C8x C 14.9800 -14.7000
2 C8x C 14.9800 -16.1000
3 C8x C 16.1700 -16.8000
4 C8y C 17.4300 -16.1000
5 C8x C 17.4300 -14.7000
6 C8y C 16.1700 -14.0000
7 S4a S 18.6200 -16.8000
8 N4y N 19.8100 -16.1000
9 O3c O 17.6400 -17.7800
10 O3c O 19.6000 -17.7800
11 C8y C 21.1400 -16.5200
12 C8y C 21.9800 -15.4000
13 C8y C 21.1400 -14.3500
14 C8x C 19.8100 -14.7700
15 C8x C 21.1400 -18.9000
16 C8x C 21.7700 -20.1600
17 C8y C 23.2400 -20.1600
18 C8x C 24.0100 -18.9700
19 C8y C 23.3100 -17.7100
20 C8y C 21.9100 -17.7100
21 X F 24.0100 -16.5200
22 C1b C 21.6300 -13.0200
23 N1b N 23.0300 -13.0200
24 C1a C 23.7300 -11.7600
25 X F 16.1700 -12.6000
26 X F 23.8700 -21.4200
27 O2a O 23.3800 -15.4000
28 C1a C 24.0800 -14.2100
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 7 9 2
10 7 10 2
11 8 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 8 14 1
16 15 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 2
21 15 20 1
22 20 11 1
23 19 21 1
24 13 22 1
25 22 23 1
26 23 24 1
27 6 25 1
28 17 26 1
29 12 27 1
30 27 28 1
|